TY - JOUR
T1 - Single-dose antibiotic treatment for symptomatic urinary tract infections in women
T2 - A meta-analysis of randomized trials
AU - Leibovici, L.
AU - Wysenbeek, Aj
PY - 1991/1
Y1 - 1991/1
N2 - The efficacy of single-dose antibiotics for treatment of symptomatic urinary tract infections in women was compared to the efficacy of conventional therapy in 25 controlled studies. The combined results of these studies indicate that single-dose antibiotics are less effective than conventional therapy at 3-14 days post-treatment (odds ratio of 0.5, 95 per cent confidence interval (C.I.) 0.4-0.7), and at 4-6 weeks (odds ratio of 0.4, 95 per cent C.I. 0.3-0.6). Single dose therapy did not perform better in patients with bacterial isolates sensitive to the drug used. The cure rate achieved by single-dose amoxicillin was significantly lower than that afforded by conventional therapy. The equal efficacy of single-dose and conventional trimethoprim/sulphamethoxazole treatment at 3-14 days post-treatment could not be ruled out with a 95 per cent certainty. However, conventional treatment achieved cure rates significantly higher than single-dose therapy at 4-6 weeks (odds ratio 0.48, 95 per cent C.I. 03-0.8). Side-effects were lower among patients given a single dose (odds ratio 0.5, 95 per cent C.I. 0.4-0.6). Although single-dose trimethroprim/sulphamethoxazole is less effective than a course of treatment, it causes fewer side-effects: the decision of whether to use a single-dose has to be decided by cost-benefit analysis in any specific health-care system.
AB - The efficacy of single-dose antibiotics for treatment of symptomatic urinary tract infections in women was compared to the efficacy of conventional therapy in 25 controlled studies. The combined results of these studies indicate that single-dose antibiotics are less effective than conventional therapy at 3-14 days post-treatment (odds ratio of 0.5, 95 per cent confidence interval (C.I.) 0.4-0.7), and at 4-6 weeks (odds ratio of 0.4, 95 per cent C.I. 0.3-0.6). Single dose therapy did not perform better in patients with bacterial isolates sensitive to the drug used. The cure rate achieved by single-dose amoxicillin was significantly lower than that afforded by conventional therapy. The equal efficacy of single-dose and conventional trimethoprim/sulphamethoxazole treatment at 3-14 days post-treatment could not be ruled out with a 95 per cent certainty. However, conventional treatment achieved cure rates significantly higher than single-dose therapy at 4-6 weeks (odds ratio 0.48, 95 per cent C.I. 03-0.8). Side-effects were lower among patients given a single dose (odds ratio 0.5, 95 per cent C.I. 0.4-0.6). Although single-dose trimethroprim/sulphamethoxazole is less effective than a course of treatment, it causes fewer side-effects: the decision of whether to use a single-dose has to be decided by cost-benefit analysis in any specific health-care system.
UR - http://www.scopus.com/inward/record.url?scp=0025966956&partnerID=8YFLogxK
U2 - 10.1093/oxfordjournals.qjmed.a068523
DO - 10.1093/oxfordjournals.qjmed.a068523
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 1670063
AN - SCOPUS:0025966956
SN - 1460-2725
VL - 78
SP - 43
EP - 57
JO - QJM - Monthly Journal of the Association of Physicians
JF - QJM - Monthly Journal of the Association of Physicians
IS - 1
ER -